Washington University head and neck surgeon Paul Zolkind, MD, and his collaborators are making great strides in their understanding of why some cancers respond well to radiation therapy and others do not. One of the most important characterizations of cancers in the past decade is the understanding that no two cancers will progress or respond […]
NRF2 pathway may mediate cancer resistance to radiation therapy
